Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (11-20 of 318) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2022
Waiting list trends for liver transplantation in Italy: A snapshot from the futureAlessio Aghemo, Quirino Lai
Gastroenterology|May 31, 2011
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hopeAlessio Aghemo, Massimo Colombo
Gastroenterology|March 29, 2016
No Time for Bullies in Hepatitis C Virus Therapy: Genotype 3 Conquered?Alessio Aghemo, Massimo Colombo
Gastroenterology|September 1, 2009
Treatment of nonresponder patients with chronic hepatitis C: to repeat or not to repeat? That is the questionAlessio Aghemo, Massimo Colombo
Journal of Hepatology|July 26, 2011
Peginterferon maintenance therapy in patients with advanced hepatitis C to prevent hepatocellular carcinoma: the plot thickensAlessio Aghemo, Massimo Colombo
Gastroenterology|June 4, 2013
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virusAlessio Aghemo, Massimo Colombo
Gastroenterology|February 26, 2014
Hepatitis C genotype 3: a tough match for interferon-free regimensAlessio Aghemo, Massimo Colombo
Gastroenterology|March 3, 2017
Response-Guided Duration of Direct Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?Alessio Aghemo, Massimo Colombo
The Lancet. Gastroenterology & Hepatology|April 19, 2017
Treatment of chronic hepatitis C: can complexity pave the way towards elimination?Federica Invernizzi, Alessio Aghemo
Liver International : Official Journal of the International Association for the Study of the Liver|March 17, 2021
Sofosbuvir in HCV patients with chronic kidney disease: No time for cautionVirginia Solitano, Alessio Aghemo
Pageof 32

Showing results (11-20 of 318) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 14, 2022
Waiting list trends for liver transplantation in Italy: A snapshot from the futureAlessio Aghemo, Quirino Lai
Gastroenterology|May 31, 2011
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hopeAlessio Aghemo, Massimo Colombo
Gastroenterology|March 29, 2016
No Time for Bullies in Hepatitis C Virus Therapy: Genotype 3 Conquered?Alessio Aghemo, Massimo Colombo
Gastroenterology|September 1, 2009
Treatment of nonresponder patients with chronic hepatitis C: to repeat or not to repeat? That is the questionAlessio Aghemo, Massimo Colombo
Journal of Hepatology|July 26, 2011
Peginterferon maintenance therapy in patients with advanced hepatitis C to prevent hepatocellular carcinoma: the plot thickensAlessio Aghemo, Massimo Colombo
Gastroenterology|June 4, 2013
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virusAlessio Aghemo, Massimo Colombo
Gastroenterology|February 26, 2014
Hepatitis C genotype 3: a tough match for interferon-free regimensAlessio Aghemo, Massimo Colombo
Gastroenterology|March 3, 2017
Response-Guided Duration of Direct Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?Alessio Aghemo, Massimo Colombo
The Lancet. Gastroenterology & Hepatology|April 19, 2017
Treatment of chronic hepatitis C: can complexity pave the way towards elimination?Federica Invernizzi, Alessio Aghemo
Liver International : Official Journal of the International Association for the Study of the Liver|March 17, 2021
Sofosbuvir in HCV patients with chronic kidney disease: No time for cautionVirginia Solitano, Alessio Aghemo
Pageof 32